Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?

Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalopoulos, George, Vrakas, Spyridon, Makris, Konstantinos, Tzathas, Charalampos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460384/
https://www.ncbi.nlm.nih.gov/pubmed/26126856
Descripción
Sumario:Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share common serologic and epidemiologic characteristics making the differentiation between those two entities difficult. We present a case of a 35-year-old woman with CD who developed SLE after treatment with adalimumab and denosumab and persisting symptoms eight months after discontinuation of those agents.

Ejemplares similares